The model does not consider differences in ADPKD progression due to PKD1 or PKD2 mutation [34, 35]; however, since genotype is a major determinant of baseline TKV [1, 36, 37], the inclusion of TKV within the model may adequately account for this limitation. Here, PKD2 is linked to autosomal dominant polycystic kidney disease.